Macquarie Group LTD Omeros Corp Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$3.04 - $4.23 $626 - $871	206 New	206 $0
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $9,425 - $30,828	-4,909 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.4 - $16.3 $58,089 - $70,660	4,335 Added 755.23%	4,909 $68,000
Q1 2021 May 14, 2021	SELL	$14.52 - $23.53 $3,949 - $6,400	-272 Reduced 32.15%	574 $10,000
Q2 2020 Aug 11, 2020	BUY	$12.21 - $16.99 $10,329 - $14,373	846 New	846 $12,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $378M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.